
    
      Forty patients will be given ramipril 10 mg and placebo, ramipril 10 mg and candesartan 16
      mg, or candesartan 16 mg and placebo daily in a randomized, double-blind, placebo-controlled
      cross-over trial with three treatment arms and two washout periods (each 2 months).
    
  